Suraksha Diagnostic Ltd's Q4FY25 Quarter Results
- 29 May 2025
Result Summary
- Suraksha Diagnostic Ltd reported a 6.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
- Its expenses for the quarter were down by 11.4% QoQ and - - YoY.
- The net profit increased 5.7% QoQ and - - YoY.
- The earnings per share (EPS) of Suraksha Diagnostic Ltd - at - during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 56.17 | 60.11 | 0.00 | -6.6% | - |
Total Expenses | 46.16 | 52.07 | 0.00 | -11.4% | - |
Profit Before Tax | 9.23 | 8.05 | - | 14.7% | NaN% |
Tax | 2.91 | 2.06 | 0.00 | 41.3% | - |
Profit After Tax | 6.32 | 5.98 | 0.00 | 5.7% | - |
Earnings Per Share | 0.00 | 1.20 | 0.00 | -100.0% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Suraksha Diagnostic Ltd is a company that specializes in providing diagnostic services and healthcare solutions. The company's primary focus is on delivering comprehensive diagnostic and pathology services to its customers. Suraksha Diagnostic Ltd operates in the healthcare industry, specifically within the diagnostic services sector. The company is known for its network of diagnostic centers offering a wide range of tests and screenings. However, specific details regarding recent major developments within the company are not available in the provided data.
Revenue
In the fourth quarter of fiscal year 2025 (Q4FY25), Suraksha Diagnostic Ltd reported a total income of ₹56.17 crores. This represents a decrease of 6.6% compared to the previous quarter (Q3FY25), where the total income was ₹60.11 crores. The data does not provide a year-over-year (YoY) comparison because the total income for Q4FY24 is listed as ₹0.00 crores. The decrease in total income on a quarter-over-quarter (QoQ) basis is a key point to note in the financial performance for this period, though the absence of year-over-year data limits a broader annual comparison.
Profitability
Suraksha Diagnostic Ltd's profitability metrics for Q4FY25 indicate a profit before tax (PBT) of ₹9.23 crores, which marks an increase of 14.7% from the previous quarter's PBT of ₹8.05 crores. The tax expense for Q4FY25 was ₹2.91 crores, reflecting an increase of 41.3% from Q3FY25's tax expense of ₹2.06 crores. Subsequently, the profit after tax (PAT) for Q4FY25 was ₹6.32 crores, showing a growth of 5.7% over the PAT of ₹5.98 crores in Q3FY25. The earnings per share (EPS) for Q4FY25 is reported as ₹0.00, compared to ₹1.20 in Q3FY25, indicating a substantial decrease of 100% QoQ. The absence of data for Q4FY24 limits a year-over-year profitability analysis.
Operating Metrics
The operating expenses for Suraksha Diagnostic Ltd in Q4FY25 were ₹46.16 crores, which is a decrease of 11.4% from the previous quarter's expenses of ₹52.07 crores. This reduction in expenses is notable when analyzing the company's operational efficiency on a quarterly basis. However, the provided data does not include specific figures for Q4FY24, making it challenging to assess YoY changes in operating expenses. Without additional data on other operating metrics such as debt-to-equity ratio or current ratio, further analysis is constrained. The trends observed are solely based on the financial data provided for the last two quarters.